首页 | 本学科首页   官方微博 | 高级检索  
检索        

miR-134靶向EGFR对非小细胞肺癌增殖的影响
引用本文:刘东利,贺小龙.miR-134靶向EGFR对非小细胞肺癌增殖的影响[J].临床肿瘤学杂志,2016,21(12):1063-1068.
作者姓名:刘东利  贺小龙
作者单位:716000 陕西延安 延安大学附属医院呼吸内科
摘    要:目的 探讨微小RNA-134(miR-134)对非小细胞肺癌(NSCLC)细胞增殖和凋亡的影响及可能的机制。方法 采用实时荧光定量PCR(QPCR)检测miR 134在NSCLC细胞株(A549、H252)和正常胚肺细胞株WI38中的表达情况;将A549和H252细胞分为3组,分别为空白对照组(不转染)、miR-NC组(转染不相关siRNA)和miR-134组(转染miR-134 mimics)。分别于转染后24、48、72、96h收集细胞,采用MTS法检测细胞的增殖情况;转染后96h用流式细胞仪检测细胞的凋亡情况;双荧光素酶报告基因实验检测miR-134与表皮生长因子受体(EGFR)3’UTR的结合情况,QPCR检测过表达miR-134的A549和H252细胞中EGFR的表达情况。结果 与WI38 细胞相比,miR-134在A549细胞中的表达下调85.91%,在H252细胞中下调78.13%(P<0.05)。MTS检测显示,miR-134能显著降低A549和H252细胞的增殖能力,并呈时间依赖性。流式细胞仪检测显示,与空白对照组比较,miR-134组A549细胞的凋亡比例提高226.31%,H252细胞提高47.85%(P<0.05)。双荧光素酶报告基因实验显示miR 134能与EGFR3’UTR结合,显著降低荧光值(P<0.05)。QPCR检测显示,与空白对照组比较,转染miR-134 mimics 后,EGFR在A549细胞中的相对表达量下调57.0%,在H252中下调35.0%,差异均有统计学意义(P<0.01)。结论 miR-134在NSCLC中低表达,能通过靶向EGFR抑制NSCLC细胞增殖,并诱导凋亡。

关 键 词:非小细胞肺癌(NSCLC)  微小RNA-134(miR-134)  表皮生长因子受体(EGFR)  增殖  凋亡

The influence of miR-134 on cell growth by targeting epidermal growth factor receptor in non-small cell lung cancer
LIU Dongli,HE Xiaolong.The influence of miR-134 on cell growth by targeting epidermal growth factor receptor in non-small cell lung cancer[J].Chinese Clinical Oncology,2016,21(12):1063-1068.
Authors:LIU Dongli  HE Xiaolong
Institution:Department of Breath Internal Medicine,Yan'an University Affiliated Hospital,Yan'an 716000,China
Abstract:Objective To investigate the effect of microRNA-134 (miR-134) on suppressing the proliferation of non-small cell lung cancer (NSCLC) and the possible mechanism.Methods The expression levels of miR-134 in NSCLC cell lines (A549,H252) and human embryo lung WI38 cells were detected by real-time quantitative-PCR (QPCR).A549 and H252 cell lines were divided into miR-NC group,miR-134 group and blank control group,which were transfected with control-siRNA,miR-134 mimics and none,respectively.The proliferation in the three groups of A549 and H252 cells was detected by MTS assays 24,48,72,96 h after transfect.Cell apoptosis were detected by flow cytometry after 96 h.A luciferase reporter assay was performed to confirm whether epidermal growth factor receptor (EGFR) was a direct target of miR-134.The expression level of EGFR was detected by QPCR.Results The level of miR-134 was found down-regulated 85.91% in A549 cells and 78.13% in H252 cells comparing with it in WI38 cells (P< 0.05).MTS assays showed that miR-134 suppressed A549 and H252 cells proliferation significantly in a time-depended manner.Flow cytometry showed that the apoptotic rate of A549 and H252 cells increased to 226.31% and 47.85% respectively compared with blank control group (P<0.05).A dual-luciferase reporter assay confirmed that EGFR was a direct target of miR-134 by reducing the activity of luciferase (P<0.05).QPCR showed that after the transfect of miR-134 mimics,the expression of EGFR down-regulated 57.0% in A549 cells and 35.0% in H252 cells compared with blank control group (P< 0.01).Conclusion miR-134 is down-regulated in NSCLC and inhibitcs cells growth,as well as induces cell apoptosis by targeting EGFR in NSCLC.
Keywords:Non-small cell lung cancer (NSCLC)  MicroRNA-134 (miR-134)  Epidermal growth factor receptor (EGFR)  Proliferation  Apoptosis
本文献已被 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号